Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06827080 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06827080
- Sponsor
- Zhengguo Chen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2026-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.